Tomoko Kasahara

Cell Therapy Using Human Induced Pluripotent Stem Cell-Derived Renal Progenitors Ameliorates Acute Kidney Injury in Mice

Takafumi Toyohara, Shin-Ichi Mae, Shin-Ichi Sueta et al. · Stem Cells Translational Medicine · 2015 · 154 citations · Full text

Medicine, Nephrology, Cell Therapy +14

Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients

Toshiaki Hitomi, Toshiyuki Habu, Hatasu Kobayashi et al. · Biochemical and Biophysical Research Communications · 2013 · 127 citations

Life Sciences, Molecular Medicine, Cardiovascular Genetics +11

A Modular Differentiation System Maps Multiple Human Kidney Lineages from Pluripotent Stem Cells

Hiraku Tsujimoto, Tomoko Kasahara, Shinichi Sueta et al. · Cell Reports · 2020 · 110 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +17

The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality

Toshiaki Hitomi, Toshiyuki Habu, Hatasu Kobayashi et al. · Biochemical and Biophysical Research Communications · 2013 · 61 citations

Life Sciences, Genetics, Molecular Genetics +14

A novel Fe(II)/α-ketoglutarate-dependent dioxygenase from<i>Burkholderia ambifaria</i>has β-hydroxylating activity of<i>N</i>-succinyl l-leucine

Makoto Hibi, Takayuki Kawashima, Tomoko Kasahara et al. · Letters in Applied Microbiology · 2012 · 32 citations

Life Sciences, Biochemistry, Microbiology +13